EMPOWER CAD is the First Prospective, Female-Only Study of Coronary Interventions
September 21, 2022
Shockwave Medical Initiates All-Female Coronary IVL Study
September 21, 2022 — Shockwave Medical, Inc., a pioneer in the development of Intravascular Lithotripsy (IVL) to treat…
Read More
Over the 10-year span, median cardiology compensation – regardless of ownership model – increased (Figure 1). From 2011 to 2021, private cardiology compensation expanded by 32% to a median of $604,652 per FTE, and integrated cardiology income increased by 13% to $621,596 per FTE.
September 21, 2022
Cardiology Compensation and New Patient Visits Rebound, Survey Finds
September 21, 2022 — MedAxiom, the premier source for cardiovascular organizational performance solutions, has released…
Read More
Statistically significant mean reductions of 10.3 mmHg in 24-hour ambulatory systolic blood pressure and 11.7 mmHg in ambulatory pulse pressure after 6 months of therapy in control patients who crossed over to BackBeat CNT following completion of the randomized portion of the MODERATO II study
September 20, 2022
Orchestra BioMed Announces Presentation of Positive Long-Term Clinical Results from MODERATO II Control Patients Crossover Extension Study of BackBeat CNT at TCT 2022
September 20, 2022 — Orchestra BioMed, Inc., a biomedical innovation company accelerating high-impact technologies to…
Read More
The LINQ II ICM is the first continuous, long-term cardiac monitor cleared by FDA for the pediatric patient population
September 20, 2022
Medtronic Receives FDA Clearance for Expanded Indication of LINQ II Insertable Cardiac Monitor For Use in Pediatric Patients Ages 2 and Older
September 20, 2022 — Medtronic, a global leader in healthcare technology, today announced the LINQ II Insertable…
Read More
Results of the CLASP IID Trial Presented at TCT and published simultaneously in JACC: Cardiovascular Interventions
September 20, 2022
Novel TEER Repair Device Meets Primary Endpoint in Treating Degenerative Mitral Regurgitation in Patients Not Eligible for Surgery
September 20, 2022 — Results of the first randomized controlled trial to directly compare two contemporary…
Read More
Results from TVT registry analysis presented at TCT and published simultaneously in the Journal of the American College of Cardiology
September 20, 2022
STS/ACC TVT Registry Analysis Assesses Use of Transcatheter Edge-to-Edge Repair in Severe Mitral Regurgitation and Cardiogenic Shock
September 20, 2022 —  An analysis from the Society of Thoracic Surgeons/American College of Cardiology(STS/ACC) TVT…
Read More
The TCT 2022 Innovation Shark Tank Competition award presentation was held Sept. 19, in Boston, MA. Shown here announcing the winner, Puzzle Medical Devices, are Robert Schwartz, MD, and Juan F. Granada, President and CEO of the Cardiovascular Research Foundation (CRF).
September 20, 2022
TCT 2022 Announces Winner of Shark Tank Innovation Award
September 19, 2022 — Puzzle Medical Devices, a provider of hemodynamic support in Heart Failure (HF), was selected as…
Read More
FIH study demonstrated feasibility and safety of cardiorenal support among patients undergoing high-risk PCI
September 19, 2022
First-in-Human Study Finds Mechanical Circulatory Support and Renal Perfusion Success with the ModulHeart Device
September 19, 2022 —  A first-in-human (FIH) study using the ModulHeart device (Puzzle Medical Devices Inc.) has…
Read More
Patent Opens Pathway to a Disruptive Ischemia and Arrhythmia Detection ECG Patch Product
September 19, 2022
HeartBeam Granted Patent for 12-Lead Electrocardiogram (ECG) Patch Monitor Intended for Detection of Heart Attacks and Complex Cardiac Arrhythmias
September 19, 2022 —  HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and…
Read More
Dr. Gagan Singh, Dr. Susheel Kodali, and Dr. Azeem Latib with principal investigator, Dr. Adrian Ebner, following the initial first-in-human cases with the Supira System.
September 19, 2022
Supira Medical Announces Successful First-in-Human Use of its Next Generation Percutaneous Ventricular Assist Device
September 19, 2022 —  Supira Medical, Inc., a Shifamed portfolio company focused on developing the next-generation…
Read More
Results also demonstrate the benefits for patients of Abbott's TriClip™ for tricuspid regurgitation, Amulet™ for atrial fibrillation and Portico™ for aortic stenosis
September 17, 2022
Late-Breaking Data Show Breadth of Abbott's Minimally Invasive Structural Heart Technologies
September 17, 2022 — Abbott today announced data from five late-breaking presentations showing the benefits of its…
Read More
Pathological Findings Confirm Importance of Early Detection and Treatment of Thrombus on Valve Leaflets
September 17, 2022
First-ever Comparison of MicroCT and Histology in Self-expanding Transcatheter Aortic Valve Replacement Patients with Hypo-attenuated Leaflet Thickening
September 17, 2022 — Medtronic today announced findings from its Pathological Study of Hypo-Attenuated Leaflet…
Read More
The Impella CP with SmartAssist heart pump is a minimally invasive, temporary heart pump that uses real-time intelligence associated with improved survival and heart recovery. (Graphic: Business Wire)
September 17, 2022
Unloading with Impella for 30 Minutes Before PCI Associated with Reduced Infarct Size in STEMI Patients
September 17, 2022 — Results of a new per-protocol analysis of the ST-segment Elevation Myocardial Infarction Door-To-…
Read More
Results from largest randomized TAVR trial to date presented at TCT 2022
September 17, 2022
Late-Breaking Data from PROTECTED TAVR Trial Demonstrate Reduced Risk of Disabling Stroke, Low Complication Rate with SENTINEL Cerebral Protection System
September 17, 2022 —  Boston Scientific Corporation has announced results from the PROTECTED TAVR clinical trial…
Read More
Edwards Lifesciences Corporation, today announced the company's PASCAL Precision transcatheter valve repair system for transcatheter edge-to-edge repair (TEER) has received FDA approval for the treatment of patients with degenerative mitral regurgitation (DMR).
September 16, 2022
Edwards Pascal Precision Transcatheter Valve Repair System Receives FDA Approval for Degenerative Mitral Regurgitation
September 16, 2022 — Edwards Lifesciences Corporation, today announced the company's PASCAL Precision transcatheter …
Read More
Results from Largest Ever Real-World Evaluation of the MANTA Device Demonstrated Safety and Effectiveness with Low Complication Rates and a Short Learning Curve
September 16, 2022
Co-Author of the Karolinska 1000 Consecutive MANTA Vascular Closure Device Study to Present Learnings at the Transcatheter Cardiovascular Therapeutics (TCT) 2022 Conference
September 16, 2022 — Teleflex Incorporated, a leading global provider of medical technologies, announced that Dr.…
Read More
The CathWorks FFRangio System to Be Featured in Multiple Live Cases and Clinical Presentations at TCT 2022
September 16, 2022
CathWorks Announces Key Events for TCT 2022
September 16, 2022 — CathWorks announced today the schedule of key events for the company during Cardiovascular…
Read More
RECOVER IV is an on-label, two arm RCT that is designed to provide the clinical evidence needed to achieve a Class I guideline recommendation for Impella use in AMI cardiogenic shock.
September 16, 2022
FDA Approves RECOVER IV Randomized Controlled Trial with Exception from Informed Consent (EFIC)
September 16, 2022 — Abiomed announced two approvals from the U.S. Food and Drug Administration (FDA) related to…
Read More
Study suggests prescribing Philips MCOT (Mobile Cardiac Outpatient Telemetry) solution may support improved patient outcomes and cost savings by monitoring for arrhythmic disturbances and encouraging timely intervention
September 15, 2022
New Study Validates Ambulatory Monitoring as a Critical Component of Cardiac Care
September 15, 2022 — Today, aortic stenosis (AS) is one of the most common and serious valve disease problems [1]. It…
Read More
Dr. Valentin Fuster to be honored with the Transcatheter Cardiovascular Therapeutics (TCT) 2022 Career Achievement Award. Image courtesy of Mount Sinai Health System
September 15, 2022
Valentin Fuster, M.D., Ph.D., Receives Prestigious Award from Cardiovascular Research Foundation
September 15, 2022 — The Cardiovascular Research Foundation (CRF) will honor Valentin Fuster, MD, PhD, Director of…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now